STAT+: Roche inks drug discovery deal with Chinese biotech, focused on molecular glue medicines

Summary

Roche has entered into a drug discovery partnership with Chinese biotech Defand Therapeutics focused on molecular glue medicines. The deal represents a collaboration between the Swiss pharmaceutical giant and an emerging Chinese biotech company in the molecular glue space.